Three life science companies unveiled Series B rounds of funding Thursday, early Christmas gifts that top $219 million combined. Along with Verge Genomics, the other companies that raised new capital are Tasso and Brainomix.
The Cedars-Sinai accelerator, which is powered by Techstars, announced its third cohort of startups this fall. Now, the 10 selected companies have unveiled deals and partnerships with various players in the healthcare space.
Employees who enjoy their benefits are more inclined to stay with their company. A 2025 Marsh McLennan Agency report said 73% of employees would remain if plan options were better.
Whittled down from roughly 600 applicants, the goals of the 10 companies in the third cohort include improving the patient experience, offering more personalized care plans for cancer treatment, triaging patients faster and making blood sample collection less painful.